Groowe Groowe / Newsroom / FHTX
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

FHTX News

Foghorn Therapeutics Inc. Common Stock

Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer

globenewswire.com
FHTX CRNX RIGL

Solid State Battery Market is Set to Reach Valuation of US$ 30.50 Billion by 2035 | Astute Analytica

globenewswire.com
CMBT FHTX MPWR SLDP IONQ INTC AMZN GOOG MSFT AAPL TSLA GM F STLA HMC

Yatiri Bio Accurately Predicts AML Drug Response in Blinded Study Using Foghorn’s FHD-286

globenewswire.com
FHTX

Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit

globenewswire.com
FHTX

Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff

prnewswire.com
ONCY NRIX ERAS FHTX ORIC

Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium

globenewswire.com
FHTX

FIRSTHABIT Successfully Concludes CES 2026 CHALK AI Math Challenge Once Again and Announces Winners

prnewswire.com
FHTX

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

globenewswire.com
FHTX

Flagship Pioneering Appoints Adrian Rawcliffe as CEO-Partner and CEO of Etiome

prnewswire.com
ADAP MRNA SANA FHTX

Platform Technologies Drive $211B Surge in Precision Cancer Treatment

prnewswire.com
GTBP ERAS FHTX OABI RXRX